Hoeltge G - Search Results

1

Acquisition of doxorubicin resistance in human leukemia HL-60 cells is reproducibly associated with 7q21 chromosomal anomalies.

Ganapathi R, Hoeltge G, Casey G, Grabowski D, Neelon R, Ford J. Ganapathi R, et al. Among authors: hoeltge g. Cancer Genet Cytogenet. 1996 Feb;86(2):116-9. doi: 10.1016/0165-4608(95)00207-3. Cancer Genet Cytogenet. 1996. PMID: 8603335

2

Modulation of doxorubicin-induced chromosomal damage by calmodulin inhibitors and its relationship to cytotoxicity in progressively doxorubicin-resistant tumor cells.

Ganapathi R, Grabowski D, Hoeltge G, Neelon R. Ganapathi R, et al. Among authors: hoeltge g. Biochem Pharmacol. 1990 Oct 1;40(7):1657-62. doi: 10.1016/0006-2952(90)90468-z. Biochem Pharmacol. 1990. PMID: 2222519

3

Functional evidence for a breast cancer growth suppressor gene on chromosome 17.

Casey G, Plummer S, Hoeltge G, Scanlon D, Fasching C, Stanbridge EJ. Casey G, et al. Among authors: hoeltge g. Hum Mol Genet. 1993 Nov;2(11):1921-7. doi: 10.1093/hmg/2.11.1921. Hum Mol Genet. 1993. PMID: 8281156

4

Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.

Kozuki T, Chikamori K, Surleac MD, Micluta MA, Petrescu AJ, Norris EJ, Elson P, Hoeltge GA, Grabowski DR, Porter ACG, Ganapathi RN, Ganapathi MK. Kozuki T, et al. Among authors: hoeltge ga. Nucleic Acids Res. 2017 Jun 2;45(10):5995-6010. doi: 10.1093/nar/gkx325. Nucleic Acids Res. 2017. PMID: 28472494 Free PMC article.

5

Frequencies and characterization of cytogenetically unrelated clones in various hematologic malignancies: seven years of experiences in a single institution.

Han JY, Theil KS, Hoeltge G. Han JY, et al. Among authors: hoeltge g. Cancer Genet Cytogenet. 2006 Jan 15;164(2):128-32. doi: 10.1016/j.cancergencyto.2005.07.013. Cancer Genet Cytogenet. 2006. PMID: 16434315

6

Proficiency testing in clinical cytogenetics. The 1986 experience of the College of American Pathologists.

Hoeltge GA, Dewald G, Miles J, Palmer C. Hoeltge GA, et al. Arch Pathol Lab Med. 1988 Nov;112(11):1085-90. Arch Pathol Lab Med. 1988. PMID: 3178421

7

Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.

Tbakhi A, Pettay J, Sreenan JJ, Abdel-Razeq H, Kalaycio M, Hoeltge G, Miller ML, Tubbs RR. Tbakhi A, et al. Among authors: hoeltge g. Am J Clin Pathol. 1998 Jan;109(1):16-23. doi: 10.1093/ajcp/109.1.16. Am J Clin Pathol. 1998. PMID: 9426513

8

Biclonal chronic lymphocytic leukemia.

Hsi ED, Hoeltge G, Tubbs RR. Hsi ED, et al. Among authors: hoeltge g. Am J Clin Pathol. 2000 Jun;113(6):798-804. doi: 10.1309/V8AN-A2XP-7TDV-HR0T. Am J Clin Pathol. 2000. PMID: 10874880

9

Proficiency testing in clinical cytogenetics. A 6-year experience with photographs, fixed cells, and fresh blood.

Hoeltge GA, Dewald G, Palmer CG, David-Nelson MA, Saikevych I, Patil S, Schwartz S, Schneider NR, Herrmann M. Hoeltge GA, et al. Arch Pathol Lab Med. 1993 Aug;117(8):776-9. Arch Pathol Lab Med. 1993. PMID: 8343040

10

A multicenter investigation with D-FISH BCR/ABL1 probes.

Dewald G, Stallard R, Alsaadi A, Arnold S, Blough R, Ceperich TM, Rafael Elejalde B, Fink J, Higgins JV, Higgins RR, Hoeltge GA, Hsu WT, Johnson EB, Kronberger D, McCorquodale DJ, Meisner LF, Micale MA, Oseth L, Payne JS, Schwartz S, Sheldon S, Sophian A, Storto P, Van Tuinen P, Wenger GD, Wiktor A, Willis LA, Yung JF, Zenger-Hain J. Dewald G, et al. Among authors: hoeltge ga. Cancer Genet Cytogenet. 2000 Jan 15;116(2):97-104. doi: 10.1016/s0165-4608(99)00120-x. Cancer Genet Cytogenet. 2000. PMID: 10640140 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters